Eloxx shareholders elect all nine director nominees, ratify Deloitte, approve say-on-pay

Eloxx Pharmaceuticals, Inc.

50,160,111 shares present (57.88% of outstanding) at June 15, 2022 annual meeting.
All nine director nominees elected; votes for ranged from 21,179,908 to 25,579,083.
Ratification of Deloitte as auditor: 49,488,639 for, 598,786 against.
Advisory vote on executive compensation approved: 24,778,473 for, 1,082,703 against.
Broker non-votes were 24,280,981 on director elections and say-on-pay.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.